当前位置: 首页 > 期刊 > 《中外医学研究》 > 201124
编号:13762955
熊去氧胆酸胶囊对黄疸型肝炎退黄的疗效观察(3)
http://www.100md.com 2011年8月25日 《中外医学研究》 201124
     [22]Yoon JH,Gores GJ.Death receptor-mediated apoptosis and the liver.J Heapatol,2002,37:400-410.

    [23]Guicciardi ME,Gores GJ.Ursodeoxycholic acid cytoprotection:dancing with death receptors and survival pathways.Hepatology,2002,35:971,973.

    [24]Azzaroli F,Mehal W,Soroka CJ,et al.Ursodeoxycholic acid diminishes Fas-ligand-induced apoptosis in mouse hepatocytes.Hepatology,2002,36:49-54.

    [25]Graf D,Kurz AK,Fischer R,et al.Taurolithocholic acid -3 sulfate induces CD95 trafficking and apoptosis in ac-jun N-terminal kinase-dependent manner.Gastroenterology,2002,122:1411-1427.

    [26]Qiao L,Yacoub A,Studer E,et al.Inhibilition of the MAPK and PI3K pathways enhances UDCA-induced apoptosis in primary rodent hepatocytes.Hepatology,2002,35:779-789.

    [27]Mitsuyoshi H,Nakashima T, et al. Ursodeoxycholic acid protects hepatocytes against oxidative injury via induction of antioxidants.Biochem Biophys Res Commun,1999,263(2):537-542.

    [28]Cvon Ritter,N.Sreejayan,et al.Ursodeoxycholic acid reduces liqid peroxidation and mucin secretagougue activity of human bile in cholesterol gallstone disease.Gastroenterology,1998,114(4):A548-A549., 百拇医药(阿色叶木•麦米提敏)
上一页1 2 3